Stage analysis of gastric cancer: a bioinformatic approach.
Gastroenterology and hepatology from bed to bench. · 01.01.2026 · 19 (1) · e10-e10
DOI: 10.22037/ghfbb.v19i01.3260 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastroenterology and hepatology from bed to bench., erschienen am 01.01.2026. Verfasst von Fatemeh Montazer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Associated Professor of Pathology, School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aim
Analysis of stage transition in gastric cancer is the aim of this project.
Background
Gastric cancer, as a lethal digestive cancer, is classified based on tumor, node, and metastasis. Early detection of gastric cancer facilitates cancer management and treatment.
Methods
Data on gene expression changes at different stages of gastric cancer are extracted from the Gene Expression Omnibus (GEO) database and evaluated using the GEO2R program to identify significantly differentially expressed genes (DEGs). The queried DEGs were enriched via Gene Ontology to explore dysregulated pathways. The crucial DEGs were identified via directed protein-protein interaction (PPI) analysis.
Results
Analyses revealed that stage IA → stage IIA and stage IB → stage IIB transitions in gastric cancer are accompanied by considerable numbers of significant DEGs. MYC, "Nitric oxide metabolism in cystic fibrosis", and "Hepatitis C and hepatocellular carcinoma" are the critical dysregulate gene and pathways in the stage IB → stage IIB transition. ACTG2, MYH11, CDKN2A, MS4A2, and FCER1A were pointed out as the critical genes in the IA → IIA stage transition.
Conclusion
In conclusion, inhibition of MYC was introduced as a crucial point in preventing the stage IB → stage IIB transition, and "Smooth muscle damage" was identified as a key process in stage IA → stage IIA transition. Experimental validation is recommended to find the applicable findings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Associated Professor of Pathology, School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
- Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Hematology-Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
- Iranian Cancer Control Center (MACSA), Tehran, Iran.
- Celiac Disease and Gluten Related Disorders Research Center, Research Institute for Gastroenterology and Liver Disease, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Zitieren
APA
Montazer, F., Rezaei-Tavirani, M., Arjmand, B., Asri, N., Razzaghi, Z., Razi, F., & Bandarian, F. (2026). Stage analysis of gastric cancer: a bioinformatic approach. Gastroenterology and hepatology from bed to bench., 19(1), e10-e10. https://doi.org/10.22037/ghfbb.v19i01.3260
Vancouver
Montazer F, Rezaei-Tavirani M, Arjmand B, Asri N, Razzaghi Z, Razi F, et al. Stage analysis of gastric cancer: a bioinformatic approach. Gastroenterology and hepatology from bed to bench.. 2026;19(1):e10-e10. doi:10.22037/ghfbb.v19i01.3260
BibTeX
@article{Montazer2026,
author = {Montazer, Fatemeh and Rezaei-Tavirani, Mostafa and Arjmand, Babak and Asri, Nastaran and Razzaghi, Zahra and Razi, Farideh and Bandarian, Fatemeh},
title = {Stage analysis of gastric cancer: a bioinformatic approach},
journal = {Gastroenterology and hepatology from bed to bench.},
year = {2026},
volume = {19},
number = {1},
pages = {e10--e10},
doi = {10.22037/ghfbb.v19i01.3260}
}
EUVIMED